Many patients have turned to LDN after other medications failed to manage their symptoms efficiently or caused undesirable side effects (Kim et al., 2020)
Pierret ACS, Mizuno Y, Saunders P, Lim E, De Giorgi R, Howes OD, McCutcheon RA, McGowan B, Sen Gupta P, Smith D, Ismail K, Pillinger T (2025) Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta- Analysis
Make Smart Swaps for Sides Entrees often come with fries, mashed potatoes, or a mound of white rice
According to Drugs.com, almost 14% of people who try Ozempic don't lose weight
Broxmeyer et al
Patients should be counseled to report severe abdominal pain immediately Gallbladder disease : Increased risk of cholelithiasis and cholecystitis, likely related to rapid weight loss Hypoglycemia : Risk is low when used alone but increases when combined with insulin or sulfonylureas Thyroid C-cell tumors : Based on rodent studies, these agents carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Acute kidney injury : Can occur, particularly with dehydration from gastrointestinal side effects Diabetic retinopathy complications : Semaglutide may worsen diabetic retinopathy in patients with diabetes, particularly with rapid improvement in glucose control Severe gastrointestinal disease : Use with caution in patients with gastroparesis or severe gastrointestinal disease
/assets/images/provider/photos/2803587.png)
